Evidence map›Paper›PMID 35695245›Full record

ArticleStatistical methods in medical research2022

Adjusting for time of infection or positive test when estimating the risk of a post-infection outcome in an epidemic.

Shaun R Seaman, Tommy Nyberg, Christopher E Overton, David J Pascall, Anne M Presanis, Daniela De Angelis

Abstract read
In one paragraph

Article in Statistical methods in medical research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. A standardised protocol for relative SARS-CoV-2 variant severity assessment, applied to Omicron BA.1 and Delta in six European countries, October 2021 to February 2022.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. No difference in risk of hospitalization between reported cases of the SARS-CoV-2 Delta variant and Alpha variant in Norway.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shaun R SeamanMRC Biostatistics Unit, 2152University of Cambridge, Cambridge, UK.ORCID 0000-0003-3726-5937
Tommy NybergMRC Biostatistics Unit, 2152University of Cambridge, Cambridge, UK.ORCID 0000-0002-9436-0626
Christopher E OvertonDepartment of Mathematics, 5292University of Manchester, UK.
David J PascallMRC Biostatistics Unit, 2152University of Cambridge, Cambridge, UK.
Anne M PresanisMRC Biostatistics Unit, 2152University of Cambridge, Cambridge, UK.
Daniela De AngelisMRC Biostatistics Unit, 2152University of Cambridge, Cambridge, UK.

Funding

Department of Health BRC-1215-20014Medical Research Council MC PC 19074Medical Research Council MC_PC_19074Medical Research Council MC_UU_00002/10Medical Research Council MC_UU_00002/11Medical Research Council MR/V038613/1Wellcome Trust 202562
6 · The paper itself

Abstract

When comparing the risk of a post-infection binary outcome, for example, hospitalisation, for two variants of an infectious pathogen, it is important to adjust for calendar time of infection. Typically, the infection time is unknown and positive test time used as a proxy for it. Positive test time may also be used when assessing how risk of the outcome changes over calendar time. We show that if time from infection to positive test is correlated with the outcome, the risk conditional on positive test time is a function of the trajectory of infection incidence. Hence, a risk ratio adjusted for positive test time can be quite different from the risk ratio adjusted for infection time. We propose a simple sensitivity analysis that indicates how risk ratios adjusted for positive test time and infection time may differ. This involves adjusting for a shifted positive test time, shifted to make the difference between it and infection time uncorrelated with the outcome. We illustrate this method by reanalysing published results on the relative risk of hospitalisation following infection with the Alpha versus pre-existing variants of SARS-CoV-2. Results indicate the relative risk adjusted for infection time may be lower than that adjusted for positive test time.

Indexed as

COVID-19EpidemicsHumansSARS-CoV-2COVID-19epidemic phase biasselection bias

Identifiers

PMID35695245
PMCPMC7613654

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.